Ana Vega

407 total citations
19 papers, 163 citations indexed

About

Ana Vega is a scholar working on Infectious Diseases, Epidemiology and Molecular Medicine. According to data from OpenAlex, Ana Vega has authored 19 papers receiving a total of 163 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Infectious Diseases, 8 papers in Epidemiology and 7 papers in Molecular Medicine. Recurrent topics in Ana Vega's work include Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Ana Vega is often cited by papers focused on Antibiotic Resistance in Bacteria (7 papers), Antibiotic Use and Resistance (4 papers) and Bacterial Identification and Susceptibility Testing (4 papers). Ana Vega collaborates with scholars based in United States, Spain and Zambia. Ana Vega's co-authors include Emily L. Heil, Kimberly C. Claeys, Jennifer Bailey, Melissa E. Badowski, Lilian M. Abbo, Carlos Zozaya, Adriana Jiménez, Lottie Hachaambwa, Luis Escosa‐García and Esther Ramos Boluda and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ana Vega

19 papers receiving 160 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Vega United States 6 62 60 55 53 33 19 163
Ana Belén Guisado-Gil Spain 9 68 1.1× 62 1.0× 97 1.8× 57 1.1× 32 1.0× 28 241
Tiffany Harris‐Brown Australia 7 50 0.8× 62 1.0× 53 1.0× 57 1.1× 36 1.1× 15 183
Kwee Yuen Tan Singapore 7 54 0.9× 99 1.6× 46 0.8× 87 1.6× 24 0.7× 12 270
Trương Anh Thư Vietnam 5 45 0.7× 76 1.3× 75 1.4× 47 0.9× 25 0.8× 9 189
Emmanuel Wey United Kingdom 10 157 2.5× 54 0.9× 50 0.9× 80 1.5× 29 0.9× 24 363
Despo Pieridou Bagatzouni Lebanon 6 46 0.7× 49 0.8× 97 1.8× 80 1.5× 23 0.7× 7 191
Rodolfo Quirós Argentina 9 39 0.6× 24 0.4× 70 1.3× 35 0.7× 19 0.6× 26 181
Zaira R. Palacios‐Baena Spain 9 65 1.0× 108 1.8× 76 1.4× 75 1.4× 50 1.5× 28 262
S. Travis King United States 12 74 1.2× 28 0.5× 36 0.7× 97 1.8× 52 1.6× 29 290
Juliano Gasparetto Brazil 9 45 0.7× 40 0.7× 82 1.5× 24 0.5× 52 1.6× 21 181

Countries citing papers authored by Ana Vega

Since Specialization
Citations

This map shows the geographic impact of Ana Vega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Vega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Vega more than expected).

Fields of papers citing papers by Ana Vega

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Vega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Vega. The network helps show where Ana Vega may publish in the future.

Co-authorship network of co-authors of Ana Vega

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Vega. A scholar is included among the top collaborators of Ana Vega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Vega. Ana Vega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Pogue, Jason M., Lilian M. Abbo, Ellen G Kline, et al.. (2025). P-1105. Effectiveness of Imipenem-Relebactam for Multidrug-resistant Pseudomonas aeruginosa in Pneumonia and Bloodstream Infections in the United States (MIRAGE). Open Forum Infectious Diseases. 12(Supplement_1). 1 indexed citations
2.
Vega, Ana, Adriana Jiménez, Octavio Martínez, et al.. (2024). Difficult-to-treat (DTR) Pseudomonas aeruginosa harboring Verona-Integron metallo-β-lactamase ( bla VIM ): infection management and molecular analysis. Antimicrobial Agents and Chemotherapy. 68(5). e0147423–e0147423. 5 indexed citations
3.
Vega, Ana, et al.. (2024). Duration of antibiotic therapy for multidrug resistant Pseudomonas aeruginosa pneumonia: is shorter truly better?. BMC Infectious Diseases. 24(1). 911–911. 4 indexed citations
4.
McCrink, Katie A., Adriana Jiménez, Gemma Roselló, et al.. (2023). Impact of a real-time diagnostic and antimicrobial stewardship workflow on time to appropriate therapy for infections caused by multidrug-resistant Gram-negative organisms. International Journal of Antimicrobial Agents. 61(6). 106811–106811. 5 indexed citations
5.
Chang, Jack, et al.. (2022). Does calculation method matter for targeting vancomycin area under the curve?. Journal of Antimicrobial Chemotherapy. 77(8). 2245–2250. 2 indexed citations
6.
Vega, Ana & Lilian M. Abbo. (2022). Rapid molecular testing for antimicrobial stewardship and solid organ transplantation. Transplant Infectious Disease. 24(5). e13913–e13913. 2 indexed citations
7.
Escosa‐García, Luis, Carlos Zozaya, Cristina Schüffelmann, et al.. (2020). Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children. Journal of Antimicrobial Chemotherapy. 76(1). 220–225. 29 indexed citations
8.
Vega, Ana, Sombo Fwoloshi, Paul Msanzya Zulu, et al.. (2020). Antimicrobial usage at a large teaching hospital in Lusaka, Zambia. PLoS ONE. 15(2). e0228555–e0228555. 24 indexed citations
9.
Vega, Ana, Emily L. Heil, Mary Banoub, et al.. (2020). Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non‐Fulminant Severe Clostridioides difficile Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(5). 398–407. 5 indexed citations
10.
Zamora, Jose Armando Gonzales, et al.. (2020). Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report. SHILAP Revista de lepidopterología. 20(7). e7998–e7998. 3 indexed citations
11.
Vega, Ana, et al.. (2020). Development and Implementation of a COVID-19 Disease Response Protocol at a Large Academic Medical Center. Disaster Medicine and Public Health Preparedness. 14(6). 792–795. 2 indexed citations
12.
Vega, Ana, Adriana Jiménez, Gemma Roselló, et al.. (2020). Implementing carbapenem-resistance testing algorithms for Enterobacteriales and Pseudomonas aeruginosa: diagnostic and antimicrobial stewardship with timely infection prevention. Diagnostic Microbiology and Infectious Disease. 97(4). 115069–115069. 5 indexed citations
13.
Salazar, Verónica, et al.. (2020). Clinical pharmacist input on HIV management may improve antiretroviral prescribing for psychiatric patients. American Journal of Health-System Pharmacy. 78(Supplement_1). S10–S15. 5 indexed citations
14.
Vega, Ana, J. Kristie Johnson, Emily L. Heil, et al.. (2019). 2433. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridioides difficile Infection in Critically Ill Patients. Open Forum Infectious Diseases. 6(Supplement_2). S841–S841. 1 indexed citations
15.
Claeys, Kimberly C., et al.. (2018). Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention. Current Infectious Disease Reports. 20(5). 7–7. 28 indexed citations
16.
Vega, Ana, et al.. (2018). 488. Oral Vancomycin Plus Intravenous Metronidazole for Severe Clostridium difficile Infection in Critically Ill Patients. Open Forum Infectious Diseases. 5(suppl_1). S181–S181. 2 indexed citations
17.
Vega, Ana, Lauren M. Hynicka, Kimberly C. Claeys, Joel V. Chua, & Emily L. Heil. (2018). Effectiveness of 8 Weeks of Ledipasvir/Sofosbuvir for Hepatitis C in HCV–HIV-Coinfected Patients. Antiviral Therapy. 24(1). 11–17. 2 indexed citations
18.
Bailey, Jennifer, et al.. (2017). A Review of HIV Pre-Exposure Prophylaxis: The Female Perspective. Infectious Diseases and Therapy. 6(3). 363–382. 33 indexed citations
19.
Vega, Ana, et al.. (2016). Commentary on Current Trends in Rising Drug Costs and Reimbursement Below Cost.. PubMed. 25(4). 41–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ana Belén Guisado-Gil Breakdown of academic impact, for papers by Tiffany Harris‐Brown Breakdown of academic impact, for papers by Kwee Yuen Tan Breakdown of academic impact, for papers by Trương Anh Thư Breakdown of academic impact, for papers by Emmanuel Wey Breakdown of academic impact, for papers by Despo Pieridou Bagatzouni Breakdown of academic impact, for papers by Rodolfo Quirós Breakdown of academic impact, for papers by Zaira R. Palacios‐Baena Breakdown of academic impact, for papers by S. Travis King Breakdown of academic impact, for papers by Juliano Gasparetto
Rankless by CCL
2026